Literature DB >> 20805465

Chk1 promotes replication fork progression by controlling replication initiation.

Eva Petermann1, Mick Woodcock, Thomas Helleday.   

Abstract

DNA replication starts at initiation sites termed replication origins. Metazoan cells contain many more potential origins than are activated (fired) during each S phase. Origin activation is controlled by the ATR checkpoint kinase and its downstream effector kinase Chk1, which suppresses origin firing in response to replication blocks and during normal S phase by inhibiting the cyclin-dependent kinase Cdk2. In addition to increased origin activation, cells deficient in Chk1 activity display reduced rates of replication fork progression. Here we investigate the causal relationship between increased origin firing and reduced replication fork progression. We use the Cdk inhibitor roscovitine or RNAi depletion of Cdc7 to inhibit origin firing in Chk1-inhibited or RNAi-depleted cells. We report that Cdk inhibition and depletion of Cdc7 can alleviate the slow replication fork speeds in Chk1-deficient cells. Our data suggest that increased replication initiation leads to slow replication fork progression and that Chk1 promotes replication fork progression during normal S phase by controlling replication origin activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20805465      PMCID: PMC2941317          DOI: 10.1073/pnas.1005031107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Regulating the licensing of DNA replication origins in metazoa.

Authors:  Melvin L DePamphilis; J Julian Blow; Soma Ghosh; Tapas Saha; Kohji Noguchi; Alex Vassilev
Journal:  Curr Opin Cell Biol       Date:  2006-05-02       Impact factor: 8.382

2.  Cdc7-Dbf4 and the human S checkpoint response to UVC.

Authors:  Timothy P Heffernan; Keziban Unsal-Kaçmaz; Alexandra N Heinloth; Dennis A Simpson; Richard S Paules; Aziz Sancar; Marila Cordeiro-Stone; William K Kaufmann
Journal:  J Biol Chem       Date:  2007-02-02       Impact factor: 5.157

3.  Cdc7 is an active kinase in human cancer cells undergoing replication stress.

Authors:  Pierluigi Tenca; Deborah Brotherton; Alessia Montagnoli; Sonia Rainoldi; Clara Albanese; Corrado Santocanale
Journal:  J Biol Chem       Date:  2006-10-24       Impact factor: 5.157

4.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

Authors:  L Meijer; A Borgne; O Mulner; J P Chong; J J Blow; N Inagaki; M Inagaki; J G Delcros; J P Moulinoux
Journal:  Eur J Biochem       Date:  1997-01-15

5.  Identification and characterization of a human protein kinase related to budding yeast Cdc7p.

Authors:  W Jiang; T Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Roscovitine targets, protein kinases and pyridoxal kinase.

Authors:  Stéphane Bach; Marie Knockaert; Jens Reinhardt; Olivier Lozach; Sophie Schmitt; Blandine Baratte; Marcel Koken; Stephen P Coburn; Lin Tang; Tao Jiang; Dong-Cai Liang; Hervé Galons; Jean-Francois Dierick; Lorenzo A Pinna; Flavio Meggio; Frank Totzke; Christoph Schächtele; Andrea S Lerman; Amancio Carnero; Yongqin Wan; Nathanael Gray; Laurent Meijer
Journal:  J Biol Chem       Date:  2005-06-23       Impact factor: 5.157

7.  Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response.

Authors:  Shannon L Maude; Greg H Enders
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

8.  ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.

Authors:  Claus Storgaard Sørensen; Randi G Syljuåsen; Jiri Lukas; Jiri Bartek
Journal:  Cell Cycle       Date:  2004-07-13       Impact factor: 4.534

9.  Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells.

Authors:  Alessia Montagnoli; Pierluigi Tenca; Francesco Sola; Daniela Carpani; Deborah Brotherton; Clara Albanese; Corrado Santocanale
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

10.  Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells.

Authors:  D A Jackson; A Pombo
Journal:  J Cell Biol       Date:  1998-03-23       Impact factor: 10.539

View more
  135 in total

1.  Activation of new replication foci under conditions of replication stress.

Authors:  P Rybak; A Waligórska; Ł Bujnowicz; A Hoang; J W Dobrucki
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place.

Authors:  Panagiotis Kotsantis; Eva Petermann; Simon J Boulton
Journal:  Cancer Discov       Date:  2018-04-13       Impact factor: 39.397

3.  The DNA damage effector Chk1 kinase regulates Cdc14B nucleolar shuttling during cell cycle progression.

Authors:  Sirisha Peddibhotla; Zhubo Wei; Rao Papineni; Micheal H Lam; Jeffrey M Rosen; Pumin Zhang
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

Review 4.  Exploiting replicative stress to treat cancer.

Authors:  Matthias Dobbelstein; Claus Storgaard Sørensen
Journal:  Nat Rev Drug Discov       Date:  2015-05-08       Impact factor: 84.694

5.  JMJD2 promotes acquired cisplatin resistance in non-small cell lung carcinoma cells.

Authors:  Lei Duan; Ricardo E Perez; Paul D Chastain; Mathew T Mathew; Divya Rani Bijukumar; Carl G Maki
Journal:  Oncogene       Date:  2019-04-09       Impact factor: 9.867

6.  CARM1 regulates replication fork speed and stress response by stimulating PARP1.

Authors:  Marie-Michelle Genois; Jean-Philippe Gagné; Takaaki Yasuhara; Jessica Jackson; Sneha Saxena; Marie-France Langelier; Ivan Ahel; Mark T Bedford; John M Pascal; Alessandro Vindigni; Guy G Poirier; Lee Zou
Journal:  Mol Cell       Date:  2021-01-06       Impact factor: 17.970

7.  Significant expression of CHK1 and p53 in bladder urothelial carcinoma as potential therapeutic targets and prognosis.

Authors:  Linfeng Zheng; Yuping Zhu; Lei Lei; Wenyong Sun; Guoping Cheng; Shifeng Yang
Journal:  Oncol Lett       Date:  2017-11-03       Impact factor: 2.967

8.  SLFN11 Blocks Stressed Replication Forks Independently of ATR.

Authors:  Junko Murai; Sai-Wen Tang; Elisabetta Leo; Simone A Baechler; Christophe E Redon; Hongliang Zhang; Muthana Al Abo; Vinodh N Rajapakse; Eijiro Nakamura; Lisa M Miller Jenkins; Mirit I Aladjem; Yves Pommier
Journal:  Mol Cell       Date:  2018-02-01       Impact factor: 17.970

9.  RECQ1 is required for cellular resistance to replication stress and catalyzes strand exchange on stalled replication fork structures.

Authors:  Venkateswarlu Popuri; Deborah L Croteau; Robert M Brosh; Vilhelm A Bohr
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

Review 10.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.